Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
25.20
+1.35 (5.66%)
At close: May 27, 2026, 4:00 PM EDT
25.22
+0.02 (0.08%)
After-hours: May 27, 2026, 7:59 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $26.61. The average 1-year stock price forecast is 5.60% higher than the current stock price, while the lowest is $21 (-16.67%) and the highest is $35 (+38.89%).
Price Target: $26.61 (+5.60%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Hold | 8 | 10 | 10 | 12 | 12 | 12 |
| Sell | 2 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Maintains $28 → $25 | Hold | Maintains | $28 → $25 | -0.79% | May 26, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $23 | Hold | Reiterates | $23 | -8.73% | May 22, 2026 |
| Barclays | Barclays | Buy Maintains $29 | Buy | Maintains | $29 | +15.08% | May 20, 2026 |
| Jefferies | Jefferies | Hold Maintains $26 → $25 | Hold | Maintains | $26 → $25 | -2.78% | May 12, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains $24 | Hold | Maintains | $24 | -4.76% | May 12, 2026 |
Financial Forecast
Revenue This Year
2.93B
from 2.35B
Increased by 24.85%
Revenue Next Year
3.49B
from 2.93B
Increased by 19.11%
EPS This Year
0.39
from 0.51
Decreased by -23.68%
EPS Next Year
0.80
from 0.39
Increased by 104.41%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.3B | 4.7B | ||||||
| Avg | 2.9B | 3.5B | ||||||
| Low | 2.6B | 3.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 41.0% | 59.9% | ||||||
| Avg | 24.8% | 19.1% | ||||||
| Low | 9.3% | 2.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.28 | 1.87 | |
| Avg | 0.39 | 0.80 | |
| Low | -0.49 | 0.36 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 150.1% | 378.0% | |
| Avg | -23.7% | 104.4% | |
| Low | - | -7.3% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.